The companies entered bankruptcy about six months after VitalSpring CEO Sreedhar Potarazu, MD, pleaded guilty to $32 million in shareholder fraud and $7.5 million in employment tax fraud.
VitalSpring and Enziime said in their bankruptcy petitions they have estimated combined liabilities of $65 million, which the companies owe to more than 350 creditors. The creditors, including several physicians and investment groups, are investors in the companies. The companies reported less than $50,000 in combined assets, according to the report.
More articles on healthcare finance:
Austin hospital closes after 133 years; relocates services
13 healthcare bankruptcies so far in 2017
CMS further delays major bundled payment initiatives: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
